ProQinase + Reaction Biology = your partner for drug discovery
ProQinase, which was recently acquired by Reaction Biology, is an industry leader and innovator for drug discovery. The combined company specializes in biochemical and cell-based assay services, protein production, and (immuno-) oncology in vivo animal models, with over 1,500 clients worldwide. With the industry's most comprehensive kinase-related discovery service portfolio comprising over 800 assays, we offer an end-to-end solution, including partnering for integrated drug discovery projects.
Your ProQinase team.